Skip to main content

Bancel Stephane's Form 4 filing

Moderna, Inc. (MRNA) · filed Sep 30, 2022

Accession no.
0001127602-22-023122
Filed
Sep 30, 2022
Trade date
Sep 28-29, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.8M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bancel StephaneCIK 0001443340Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 28, 2022Common StockMOption exerciseAcquired+40,000$0.99+$39,6005,451,946Direct
Sep 28, 2022Common StockSSaleDisposed−19,223$122.30F2−$2,350,972.95,432,723Direct
Sep 28, 2022Common StockSSaleDisposed−13,099$123.41F3−$1,616,547.595,419,624Direct
Sep 28, 2022Common StockSSaleDisposed−7,678$124.36F4−$954,836.085,411,946Direct
Sep 29, 2022Common StockMOption exerciseAcquired+40,000$0.99+$39,6005,451,946Direct
Sep 29, 2022Common StockSSaleDisposed−9,270$115.76F5−$1,073,095.25,442,676Direct
Sep 29, 2022Common StockSSaleDisposed−18,415$116.66F6−$2,148,293.95,424,261Direct
Sep 29, 2022Common StockSSaleDisposed−12,015$117.70F7−$1,414,165.55,412,246Direct
Sep 29, 2022Common StockSSaleDisposed−300$118.19F8−$35,4575,411,946Direct
Sep 29, 2022Common StockSSaleDisposed−10,000$119.82−$1,198,2006,694,880Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 28, 2022Common StockMOption exerciseDisposed−40,000$0.00$03,107,155Direct
Sep 29, 2022Common StockMOption exerciseDisposed−40,000$0.00$03,067,155Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $121.96 to $122.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.97 to $123.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $123.98 to $124.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.12 to $116.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.13 to $117.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $117.15 to $118.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.19 to $118.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)